PE20020718A1 - 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos - Google Patents
2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicosInfo
- Publication number
- PE20020718A1 PE20020718A1 PE2001001260A PE2001001260A PE20020718A1 PE 20020718 A1 PE20020718 A1 PE 20020718A1 PE 2001001260 A PE2001001260 A PE 2001001260A PE 2001001260 A PE2001001260 A PE 2001001260A PE 20020718 A1 PE20020718 A1 PE 20020718A1
- Authority
- PE
- Peru
- Prior art keywords
- substituted
- alkyl
- aryl
- azethydinones
- hypocholesterolemic agents
- Prior art date
Links
- 239000003529 anticholesteremic agent Substances 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 abstract 1
- 229960000815 ezetimibe Drugs 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A 2-AZETIDINONAS SUSTITUIDAS DE FORMULA I DONDE R26 ES OH, OCH3, F, Cl; R1 ES H, GRUPO a, ENTRE OTROS; R2 ES H, ALQUILO C1-C6, ENTRE OTROS; R3, R4 Y R5 SON H, ALQUILO C1-C6, ARILO, ARIL ALQUILO C1-C6, ENTRE OTROS; AR1 ES ARILO, ARILO R10-SUSTITUIDO; AR2 ES ARILO O ARILO R11-SUSTITUIDO; Q ES -(CH2)q- DONDE q ES 2-6, ENTRE OTROS; R2 ES H, ALQUILO C1-C6, ARILO, ARILALQUILO C1-C6; R3, R4 Y R5 SON H, ALQUILO C1-C6, ARILALQUILO C1-C6, ENTRE OTROS; R10 Y R11 SON ALQUILO C1-C6, OR19, -O(CO)R19, ENTRE OTROS; R19 ES H, ALQUILO C1-C6, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS DE 2-AZETIDINONAS SUSTITUIDAS CON AZUCARES SON AGENTES HIPOCOLESTEROLEMICOS UTILES EN LA PREVENCION DE ATEROSCLEROSIS. EZETIMIBE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25687500P | 2000-12-20 | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020718A1 true PE20020718A1 (es) | 2002-08-09 |
Family
ID=22973953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001001260A PE20020718A1 (es) | 2000-12-20 | 2001-12-17 | 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20020137690A1 (es) |
| EP (1) | EP1347987B1 (es) |
| JP (2) | JP4351842B2 (es) |
| KR (1) | KR100883461B1 (es) |
| CN (1) | CN100475829C (es) |
| AR (1) | AR035611A1 (es) |
| AT (2) | ATE279425T1 (es) |
| AU (2) | AU3104902A (es) |
| BR (1) | BR0116212A (es) |
| CA (1) | CA2432798C (es) |
| CY (1) | CY1106912T1 (es) |
| CZ (1) | CZ302193B6 (es) |
| DE (2) | DE60129863T2 (es) |
| DK (2) | DK1593670T3 (es) |
| EC (1) | ECSP034659A (es) |
| ES (2) | ES2287826T3 (es) |
| GE (1) | GEP20053548B (es) |
| HU (1) | HUP0302269A3 (es) |
| IL (1) | IL155771A0 (es) |
| MA (1) | MA26975A1 (es) |
| MX (1) | MXPA03005671A (es) |
| MY (1) | MY129148A (es) |
| NO (2) | NO326981B1 (es) |
| NZ (1) | NZ525722A (es) |
| PE (1) | PE20020718A1 (es) |
| PL (1) | PL208242B1 (es) |
| PT (2) | PT1593670E (es) |
| RU (1) | RU2297422C2 (es) |
| SI (2) | SI1347987T1 (es) |
| SK (1) | SK286703B6 (es) |
| TR (1) | TR200402758T4 (es) |
| TW (1) | TWI316942B (es) |
| WO (1) | WO2002050090A1 (es) |
| ZA (1) | ZA200303694B (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| SK288217B6 (sk) | 2001-01-26 | 2014-08-05 | Merck Sharp & Dohme Corp. | Zmes, terapeutická kombinácia, farmaceutický prostriedok a ich použitie |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| BRPI0206641B8 (pt) | 2001-01-26 | 2021-05-25 | Merck Sharp & Dohme | uso de um inibidor da absorção de esteróis |
| RS50386B (sr) | 2001-03-28 | 2009-12-31 | Schering Corporation, | Enantioselektivna sinteza intermedijarnih jedinjenja azetidinona |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| DE60216300T2 (de) | 2001-09-21 | 2007-06-28 | Schering Corp. | Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| GB0215579D0 (en) * | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| AR040588A1 (es) | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
| AU2003291719A1 (en) | 2002-11-06 | 2004-06-03 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| CA2517573C (en) | 2003-03-07 | 2011-12-06 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| ES2311806T3 (es) | 2003-03-07 | 2009-02-16 | Schering Corporation | Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| JP2005015434A (ja) | 2003-06-27 | 2005-01-20 | Kotobuki Seiyaku Kk | 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤 |
| EP1522541A1 (en) * | 2003-10-07 | 2005-04-13 | Lipideon Biotechnology AG | Novel hypocholesterolemic compounds |
| EP1918000A2 (en) | 2003-11-05 | 2008-05-07 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| ATE485267T1 (de) * | 2003-12-23 | 2010-11-15 | Astrazeneca Ab | Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung |
| AU2004308332B2 (en) | 2003-12-23 | 2008-04-10 | Merck Sharp & Dohme Corp. | Anti-hypercholesterolemic compounds |
| GB0329778D0 (en) * | 2003-12-23 | 2004-01-28 | Astrazeneca Ab | Chemical compounds |
| WO2006039334A1 (en) * | 2004-09-29 | 2006-04-13 | Schering Corporation | Combinations of substituted azetidonones and cb1 antagonists |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| AR054482A1 (es) * | 2005-06-22 | 2007-06-27 | Astrazeneca Ab | Derivados de azetidinona para el tratamiento de hiperlipidemias |
| SA06270191B1 (ar) * | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| US20070275075A1 (en) * | 2006-03-06 | 2007-11-29 | Ilan Zalit | Ezetimibe compositions |
| TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
| AU2008232419B2 (en) * | 2007-04-02 | 2013-06-20 | Theracos, Inc. | Benzylic glycoside derivatives and methods of use |
| US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
| MX2011008470A (es) * | 2009-02-11 | 2011-09-15 | Dow Agrosciences Llc | Composiciones pesticidas. |
| WO2010100255A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
| US9388440B2 (en) | 2009-04-01 | 2016-07-12 | Mylan Laboratories Limited | Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of Ezetimibe and further conversion to Ezetimibe |
| CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
| KR101102749B1 (ko) * | 2009-11-30 | 2012-01-05 | 최길용 | 곱셈 학습기 |
| KR20150079373A (ko) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| CN105055404B (zh) * | 2015-08-19 | 2017-07-18 | 四川大学 | Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3595B (en) * | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5627176A (en) * | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5633246A (en) * | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| CZ293957B6 (cs) * | 1995-10-31 | 2004-08-18 | Scheringácorporation | @@Azetidinony substituované cukernými zbytkyŹ použitelné jako hypocholesterolemikaŹ farmaceutický prostředek a kit je obsahující |
| US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| AUPQ342599A0 (en) * | 1999-10-14 | 1999-11-04 | University Of Melbourne, The | Conjugates and uses thereof |
-
2001
- 2001-12-17 EP EP01991315A patent/EP1347987B1/en not_active Expired - Lifetime
- 2001-12-17 NZ NZ525722A patent/NZ525722A/en not_active IP Right Cessation
- 2001-12-17 KR KR1020037007778A patent/KR100883461B1/ko not_active Expired - Fee Related
- 2001-12-17 AR ARP010105837A patent/AR035611A1/es not_active Application Discontinuation
- 2001-12-17 TR TR2004/02758T patent/TR200402758T4/xx unknown
- 2001-12-17 SK SK770-2003A patent/SK286703B6/sk not_active IP Right Cessation
- 2001-12-17 US US10/023,295 patent/US20020137690A1/en not_active Abandoned
- 2001-12-17 ES ES05004699T patent/ES2287826T3/es not_active Expired - Lifetime
- 2001-12-17 CN CNB01821133XA patent/CN100475829C/zh not_active Expired - Fee Related
- 2001-12-17 AU AU3104902A patent/AU3104902A/xx active Pending
- 2001-12-17 JP JP2002551983A patent/JP4351842B2/ja not_active Expired - Fee Related
- 2001-12-17 DK DK05004699T patent/DK1593670T3/da active
- 2001-12-17 PE PE2001001260A patent/PE20020718A1/es not_active Application Discontinuation
- 2001-12-17 PT PT05004699T patent/PT1593670E/pt unknown
- 2001-12-17 DE DE60129863T patent/DE60129863T2/de not_active Expired - Lifetime
- 2001-12-17 DK DK01991315T patent/DK1347987T3/da active
- 2001-12-17 BR BR0116212-8A patent/BR0116212A/pt active Search and Examination
- 2001-12-17 AT AT01991315T patent/ATE279425T1/de active
- 2001-12-17 AU AU2002231049A patent/AU2002231049B2/en not_active Ceased
- 2001-12-17 PL PL363237A patent/PL208242B1/pl not_active IP Right Cessation
- 2001-12-17 WO PCT/US2001/049127 patent/WO2002050090A1/en not_active Ceased
- 2001-12-17 PT PT01991315T patent/PT1347987E/pt unknown
- 2001-12-17 HU HU0302269A patent/HUP0302269A3/hu unknown
- 2001-12-17 CZ CZ20031674A patent/CZ302193B6/cs not_active IP Right Cessation
- 2001-12-17 IL IL15577101A patent/IL155771A0/xx not_active IP Right Cessation
- 2001-12-17 CA CA002432798A patent/CA2432798C/en not_active Expired - Fee Related
- 2001-12-17 MX MXPA03005671A patent/MXPA03005671A/es active IP Right Grant
- 2001-12-17 RU RU2003122520/04A patent/RU2297422C2/ru not_active IP Right Cessation
- 2001-12-17 SI SI200130228T patent/SI1347987T1/xx unknown
- 2001-12-17 AT AT05004699T patent/ATE369334T1/de active
- 2001-12-17 ES ES01991315T patent/ES2230385T3/es not_active Expired - Lifetime
- 2001-12-17 DE DE60106489T patent/DE60106489T2/de not_active Expired - Lifetime
- 2001-12-17 SI SI200130760T patent/SI1593670T1/sl unknown
- 2001-12-18 TW TW090131349A patent/TWI316942B/zh not_active IP Right Cessation
- 2001-12-19 MY MYPI20015742A patent/MY129148A/en unknown
-
2003
- 2003-05-13 ZA ZA200303694A patent/ZA200303694B/en unknown
- 2003-06-19 EC EC2003004659A patent/ECSP034659A/es unknown
- 2003-06-19 NO NO20032806A patent/NO326981B1/no not_active IP Right Cessation
- 2003-06-19 MA MA27205A patent/MA26975A1/fr unknown
-
2004
- 2004-11-19 GE GEAP8505A patent/GEP20053548B/en unknown
-
2007
- 2007-10-08 CY CY20071101279T patent/CY1106912T1/el unknown
-
2008
- 2008-08-29 NO NO20083737A patent/NO20083737L/no not_active Application Discontinuation
-
2009
- 2009-03-25 JP JP2009075266A patent/JP2009132745A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020718A1 (es) | 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos | |
| TR200200225T2 (tr) | İkameli okzo azahetrosiklil bileşikleri | |
| NO970495L (no) | Aryltioforbindelser som anti-bakterielle og antivirale midler | |
| PE20000049A1 (es) | Nuevos macrolidos | |
| CY1111071T1 (el) | Φαρμακευτικες ενωσεις που περιεχουν τα παραγωγα αζετιδινης, τα νεα παραγωγα αζετιδινης και η παρασκευη τους | |
| CO4990929A1 (es) | Compuestos de difenilurea sustituidos con sulfonamidas como antagonistas de los receptores de il-8 | |
| NL350075I2 (es) | ||
| TW200510368A (en) | Pharmaceutical compositions and combinations of novel non-imidazole compounds | |
| TR199902372A2 (xx) | Sulfanilsilanlar. | |
| AP9901442A0 (en) | 4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists. | |
| PE20060977A1 (es) | Derivados de piperidinilo como bloqueantes de canales de calcio | |
| AR036391A1 (es) | Uso de un compuesto de prostaglandina para preparar una composicion farmaceutica para abrir los canales de cic en un mamifero y compuestos de prostaglandina | |
| ES2176698T3 (es) | Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| PE20001289A1 (es) | Nuevos antibioticos macrolidos | |
| PE20040531A1 (es) | Derivados de isoindolona, proceso de preparacion, compuestos intermedios de este proceso y composiciones farmaceuticas que los contienen | |
| ATE276223T1 (de) | Flüssigkristalline verbindungen | |
| TR200201613T2 (tr) | Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler | |
| CO4940446A1 (es) | Compuestos 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos | |
| ES2161201T1 (es) | Derivado de benzamida, composiciones que contienen dicho derivado y su empleo. | |
| BR0214401A (pt) | Composição aquosa de cimento | |
| AR023381A1 (es) | Nuevo derivado de tiazolbenzoimidazol | |
| TW200505446A (en) | Inhibitor of cox | |
| EP1715029A3 (en) | Process for the treatment of textile fibre materials | |
| AR053560A1 (es) | Compuestos antibacterianos de 3,3' dialcoxi-2,2' -dihidroxi -1,1' -bifenilo 5,5' disustituidos y metodos relacionados | |
| DE60040396D1 (de) | Verbesserte, kohle enthaltende materialien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |